James Hallinan

Talk to me about all things drug discovery, from small molecules to biologics to cell & gene therapies

[Evotec @Evotec]

Evotec SE announced today that Evotec has entered a technology development partnership with Novo Nordisk in cell therapy.
https://t.co/6agcLeBgyc
#TogetherForMedicinesThatMatter #CellTherapy

[Evotec @Evotec]

Join us at Booth #B20 at ELRIG Drug Discovery!

Don't miss Sven Schreiter's talk on "Automated High Content Screening", Oct 3rd, 12:15 PM.

And Saman Honarnejad will be co-chairing the "Advances in Assay Development and Screening" track.

More details: https://t.co/ak3WpABNEK

[Evotec @Evotec]

Evotec at Advanced Therapies Europe (ATE)!

Our VP of ATMP Global Regulatory Affairs, Michela Gabaldo, will chair a panel on: Accelerating Cell and Gene Therapy Innovation: Regulatory Pathways in Europe.

Learn more: https://t.co/VehL88Wyld

#ATE #Biotech #CellandGeneTherapy

[Evotec @Evotec]

Join the Technology Networks online symposium, Advances in Drug Discovery & Development 2024 from 18 - 19 September 2024.

Our VP RNA Biology, Dr. Steffen Grimm, is presenting on "Drug Development in the RNA world"..

https://t.co/okkfDFwXxy

[Evotec @Evotec]

We will delve into the latest advancements in microRNA research, exploring the therapeutic potential of #miRNA-targeting treatments, in our upcoming #oligonucleotide therapies webinar, "Unlocking the Potential of miRNA-Targeted Therapies".
Register here- https://t.co/UMO44wPd6C

[Evotec @Evotec]

Have you registered already?

This Wednesday, we are continuing our webinar series on hit identification strategies at Evotec.

Please register now for episode 4 "The Role of Structural Insights in Drug Discovery"

https://t.co/OoYuAh1GKS

[Evotec @Evotec]

Evotec is supporting Advanced Therapies Europe #ATE24 as an Associate Sponsor, and our colleagues are representing our approach and our expertise to deliver iPSC-based cell therapeutics within various sessions. Learn more here- https://t.co/MuQik1cFdH

#CellTherapy

[James Hallinan @SynBioJamesH]

@AnneOsbourn1 So sorry to hear this news Anne

[Evotec @Evotec]

Evotec announced that the Company entered a partnership with Inserm, the French National Institute of Health and Medical Research, Lille University Hospital and Inserm Transfert (the private subsidiary of Inserm).

Learn more read the full press release- https://t.co/3ESRCTrgdE

[Evotec @Evotec]

Watch @JustEvotecBio's first virtual roundtable on #continuousmanufacturing of #biologics. For this session we invited @Vir_Biotech as they discuss "How real is continuous manufacturing and what are the challenges?". Stream it now - https://t.co/bQGnfuTASD

#researchneverstops

[Evotec @Evotec]

Heartfelt thanks to BSTP for choosing Evotec Verona to host their annual meeting! It has been a pleasure to welcome these brilliant minds for scientific discussions about the future of cell therapy and the crucial role of pathology in this field #BSTPASM2023 #researchneverstops

[Evotec @Evotec]

This month, join Evotec in Brussels at the European Society of Gene and Cell Therapy conference where our experts will present a scientific poster on AAV-based vectors. Meet the team at Booth #8 | Get in touch to book a meeting - https://t.co/g8RwmPwBTH
#researchneverstops

[Evotec @Evotec]

We're thrilled to announce our presence at #ELRIG2023 | Join us at Booth #B9 to explore the latest in drug discovery innovations. Schedule a meeting with our experts, Helen Box & James Hallinan - [email protected] #ELRIG2023 #DrugDiscovery #Innovation #researchneverstops

[Evotec @Evotec]

Evotec is excited to participate in the iPSC-Derived Cell Therapies Summit in Boston this week. Our experts will present oral and scientific poster presentations | Discover more - https://t.co/KygTPrYBXB #researchneverstops #iPSC #celltherapy

[Evotec @Evotec]

Join Evotec in Brussels next month at #ESGCT23 where our experts will present on AAV-based vectors | Meet the team at booth #8 to discuss your gene and cell therapy requirements | Get in touch to book a meeting - [email protected] #researchneverstops

[James Hallinan @SynBioJamesH]

So of all the exciting and innovative technology and product development consultancies in Cambridge, only one seems to have made the jump to... https://t.co/kwTzArxiK3

[James Hallinan @SynBioJamesH]

@BBCTomFeilden @BBCr4today Desmond Bagley wrote a rip-roaring adventure thriller about this in 1984 - Night of Error. #nothingnewunderthesun

[James Hallinan @SynBioJamesH]

I had a great day earlier this week at the @BabrahamInst - have a look at my report: Data and what to do with it in advanced therapies https://t.co/tWu2gqe3qV via @LinkedIn

[James Hallinan @SynBioJamesH]

It's #InternationalWomenInEngineeringDay - who are the women engineers that have inspired & impressed you? I'm lucky to have known @ELNSMNS and Mary Karavenglemann, both excellent biomedical engineers, and collaborated with @NeekaMashouf who is an amazing innovator @rubi_earth

[James Hallinan @SynBioJamesH]

A nice thing about living near @Cambridge_Uni is the range of seminars open to the public. Today's great presentation by Kelly Monk of @MonkLab1 at @VollumInstitute was on oligodendrocyte precursor cells, an exciting target for #genetherapy for #MultipleSclerosis @CentreMyelin